| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/06/2011 | EP2091513B1 Ejection liquid and ejection method |
| 04/06/2011 | EP1945228B1 Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| 04/06/2011 | EP1729813B1 Inclusion complexes containing piroxicam, a cyclodextrin and arginine |
| 04/06/2011 | EP1469876B1 Antimicrobial cationic peptides and formulations thereof |
| 04/06/2011 | EP1467749B1 Thrombin derived peptides for promoting cardiac tissue repair |
| 04/06/2011 | EP1411979B1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv |
| 04/06/2011 | EP1404356B1 Method for designing cd10-activated prodrug compounds |
| 04/06/2011 | EP1404324B2 Prodrugs of gaba analogs, compositions and uses thereof |
| 04/06/2011 | EP1183048B1 Polymers, compositions and methods of use for foams, laundry detergents, shower rinses, and coagulants |
| 04/06/2011 | CN201782981U 一种提高微生态制剂与相关活性成份安定性及效用的结构 Probiotics with a way to improve the stability and effectiveness of the active ingredient associated structures |
| 04/06/2011 | CN1993119B Composition containing statins and omega-3 fatty acids |
| 04/06/2011 | CN1942171B Liquids containing suspended glass particles |
| 04/06/2011 | CN1883710B Chemical modification method of antineoplastic oligopeptide and application thereof |
| 04/06/2011 | CN1762495B Long acting sustained-release formulation containing dopamine-receptor stimulant medicine and its preparation process |
| 04/06/2011 | CN1376146B Solid-state form of celecoxil having enhanced bioavailability |
| 04/06/2011 | CN102007217A Enzymatic conjugation of bioactive moieties |
| 04/06/2011 | CN102006890A Targeting lipids |
| 04/06/2011 | CN102006863A Film-like composition |
| 04/06/2011 | CN102006861A Orally disintegrating tablets |
| 04/06/2011 | CN102006858A Compositions for the treatment of lice |
| 04/06/2011 | CN102002117A Branched chitosan derivative and preparation method thereof |
| 04/06/2011 | CN102002096A Amphipathic compound using somatostatin analogue as target radical and pharmaceutics application thereof |
| 04/06/2011 | CN102002049A Antigen and preparation method and application thereof |
| 04/06/2011 | CN102000346A Nanometer nucleic acid guide medicine, and preparation method and application thereof |
| 04/06/2011 | CN102000345A Complex folic acid/beta-cyclodextrin composite and preparation method thereof |
| 04/06/2011 | CN102000344A Medicament coating composition with masked taste |
| 04/06/2011 | CN102000343A Protective agent of live bacillus subtilis preparation |
| 04/06/2011 | CN102000342A Preparation method of superparamagnetism conductive nano gamma-ferric oxide/ polyaniline-dexamethasone sodium phosphate |
| 04/06/2011 | CN102000341A Polyethylene oxide and matrix type surfactant in suppository composition |
| 04/06/2011 | CN102000340A Targeted polymer medicament carrier and preparation method and application thereof |
| 04/06/2011 | CN102000339A Drug carrier capable of realizing sustained release of drug |
| 04/06/2011 | CN102000338A Silicon dioxide pellet and preparation method thereof |
| 04/06/2011 | CN102000335A Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
| 04/06/2011 | CN102000324A Long-efficiency and stable animal interferon solution preparation and preparation method thereof |
| 04/06/2011 | CN102000236A Method for preparing volatile oil inclusion compound and application thereof |
| 04/06/2011 | CN102000113A Method for preparing nano donkey-hide gelatin granules with polymer as carrier |
| 04/06/2011 | CN102000109A Pharmaceutical preparation using hydrogen as therapeutic substance and preparation method thereof |
| 04/06/2011 | CN102000108A Gynaecological medicine composition as well as external-use capsule and application thereof |
| 04/06/2011 | CN102000094A Ibandronic acid-containing medicinal composition and preparation process thereof |
| 04/06/2011 | CN102000083A Levofloxacin hydrochloride medicinal composition for injection and preparation method thereof |
| 04/06/2011 | CN102000080A Method for solubilizing camptothecin compound |
| 04/06/2011 | CN102000076A Combinatorial medicament of pantoprazole sodium |
| 04/06/2011 | CN102000065A Anti-cancer formulation |
| 04/06/2011 | CN102000050A Nimesulide medicine composition for improving dissolution performance and preparation method thereof |
| 04/06/2011 | CN102000042A Controlled release preparations |
| 04/06/2011 | CN102000041A Furadantin capsule containing quick-release component and slow-release component and preparation method thereof |
| 04/06/2011 | CN102000040A Febuxostat capsule drug combination and preparation method thereof |
| 04/06/2011 | CN102000039A Stable iloperidone capsule medicament composite |
| 04/06/2011 | CN102000037A Sublingual naloxone hydrochloride dripping pill |
| 04/06/2011 | CN102000033A Amoxicillin particle and preparation process thereof |
| 04/06/2011 | CN102000032A Method for preparing ketoprofen slow release preparation |
| 04/06/2011 | CN102000029A Strontium ranelate dry suspension |
| 04/06/2011 | CN102000027A Clevidipine butyrate medium-length chain fat emulsion and preparation method thereof |
| 04/06/2011 | CN102000024A Moxifloxacin hydrochloride injection, preparation method and application thereof |
| 04/06/2011 | CN102000023A Momestasone furoate cream and preparation method thereof |
| 04/06/2011 | CN102000021A Stable chlorine dioxide sustained-release gel preparation and preparation method and application thereof |
| 04/06/2011 | CN102000020A Novel micro-needle patch containing degradable polymer and preparation method thereof |
| 04/06/2011 | CN102000019A Amitraz transdermal agent and preparation method thereof |
| 04/06/2011 | CN102000018A Solid dispersion containing celecoxib as well as preparation method and application thereof |
| 04/06/2011 | CN101757347B Clinopodium polycephalum band-aid and preparation method thereof |
| 04/06/2011 | CN101697988B Taste hiding composition and application thereof in Xuesaitong chewable tablet |
| 04/06/2011 | CN101618021B Chitosan coating medicine slow release microsphere and preparation method thereof |
| 04/06/2011 | CN101612114B Recombinant human interferon a2b suppository and preparation method thereof |
| 04/06/2011 | CN101596174B Soft capsule and preparation method thereof |
| 04/06/2011 | CN101569655B Radix astragali gastric floating tablet suitable for treating chronic superficial gastritis |
| 04/06/2011 | CN101537186B Vaccine freeze-drying protective agent without gelatin |
| 04/06/2011 | CN101491529B Preparation method of piroxicam belta-cyclodextrin inclusion compound micro-pill capsules |
| 04/06/2011 | CN101474163B Lovastatin and niacin sustained-release preparation and preparation method thereof |
| 04/06/2011 | CN101474158B Preparation method of vitamin B6 granule for direct tablet forming |
| 04/06/2011 | CN101461787B Preparation method of hydroxycamptothecin nano crystal lyophilized powder for injection preparation |
| 04/06/2011 | CN101439026B Controlled release preparation containing doxazosin or salt thereof and preparation method thereof |
| 04/06/2011 | CN101426487B Formulations containing amide derivatives of carboxylic acidnsaids for topical administration to the eye |
| 04/06/2011 | CN101422441B Nimesulide sustained-release tablet and preparation method thereof |
| 04/06/2011 | CN101417122B Recombination chicken alpha-interferon injection and preparation method thereof |
| 04/06/2011 | CN101361829B Traditional Chinese medicine for treating rheumatism, atrophic arthritis and preparation method thereof |
| 04/06/2011 | CN101323022B Method for preparing gold magnetic core-shell nano-particle |
| 04/06/2011 | CN101322778B Double-layer sustained release tablets for compensating iron and preparation thereof |
| 04/06/2011 | CN101301283B Composition transferred through nose and brain containing milnacipran |
| 04/06/2011 | CN101299994B Use of a copolymer in the form of a solubiliser for a poorly water-soluble compound |
| 04/06/2011 | CN101279096B Pullulan polysaccharide Vc coating combination |
| 04/06/2011 | CN101185638B Microemulsion preparation and preparation method thereof |
| 04/06/2011 | CN101152164B Anti-cicatrix externally used pad pasting containing anti-hypertrophy cell medicament and method for preparing the same |
| 04/06/2011 | CN101146524B A transdermal topical composition and its uses |
| 04/06/2011 | CN101062078B Extract of stevia whole stevioside and stevia whole flavone and the preparing method thereof |
| 04/06/2011 | CN101056623B Stabilized freeze-dried formulation for cephalosporin derivatives |
| 04/06/2011 | CN101020054B Inactivated vaccine for preventing and treating paramyxovirus disease of pigeon and its preparation |
| 04/05/2011 | US7919572 Polyamino acids functionalised with at least one hydrophobic group and applications thereof particularly therapeutic applications |
| 04/05/2011 | US7919525 Radiation protection by gamma-tocotrienol |
| 04/05/2011 | US7919477 Multiple CpG oligodeoxynucleotides and their use to induce an immune response |
| 04/05/2011 | US7919474 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 04/05/2011 | US7919473 IRNA agents targeting VEGF |
| 04/05/2011 | US7919458 Method of inhibiting prostate cancer cell proliferation |
| 04/05/2011 | US7919454 Methods of treating using conjugates transported by a PEPT2 transporter |
| 04/05/2011 | US7919182 Pressure-sensitive adhesive sheet for application to skin |
| 04/05/2011 | US7919128 Mixture of alkali metal oxide, hydroxide |
| 04/05/2011 | US7919123 Composition and method for treating or preventing gastrointestinal cancer |
| 04/05/2011 | US7919118 Spacer moiety for poly (ethylene glycol) modified peptide based compounds |
| 04/05/2011 | US7919109 Apparatus for uniform delivery of drugs to biological systems |
| 04/05/2011 | US7919076 PH-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 04/05/2011 | CA2739682A1 Topical nsaid compositions having sensate component |